TorreyPines Therapeutics Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Investors
  • 1

TorreyPines Therapeutics General Information

Description

Developer of novel small molecules intended to treat diseases and disorders of the central nervous system. The company leverages technology to discover and develop novel small molecules to treat conditions like chronic pain, migraine, schizophrenia, and Alzheimer's disease, enabling clients to better treat conditions with fewer side effects

Contact Information

Website
torreypinestherapeutics.com
Formerly Known As
Neurogenetics, Neurogenetics Inc
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 11085 North Torrey Pines Road
  • Suite 300
  • San Diego, CA 92037
  • United States
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Acquirer
Raptor Pharmaceuticals
Vertical(s)
Life Sciences
Corporate Office
  • 11085 North Torrey Pines Road
  • Suite 300
  • San Diego, CA 92037
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TorreyPines Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 28-Sep-2009 000.00 Completed Profitable
6. Reverse Merger 04-Oct-2006 000.00 Completed Profitable
5. Later Stage VC (Series C2) 05-Jul-2006 00.000 000.00 Completed Generating Revenue
4. Later Stage VC 25-Oct-2005 00.000 000.00 Completed Generating Revenue
3. Early Stage VC 15-Dec-2004 000.00 000.00 Completed Startup
2. Early Stage VC (Series B) 03-Oct-2002 $19.1M $19.1M Completed Startup
1. Early Stage VC 01-Apr-2000 Completed Startup
To view TorreyPines Therapeutics’s complete valuation and funding history, request access »

TorreyPines Therapeutics Patents

  • 22

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 4

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

TorreyPines Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2553033-A1 Methods for treatment of complications of diabetes Inactive 30-Jan-2004 000000000
AU-2003259965-A1 Methods and compositions for modulating amyloid beta Inactive 20-Aug-2002 00000000000
AU-2003265607-A1 Method of modulating and of identifying agents that modulate intracellular calcium Inactive 20-Aug-2002 00000000000
AU-2003265607-A8 Method of modulating and of identifying agents that modulate intracellular calcium Inactive 20-Aug-2002 00000000000
AU-2003259965-A8 Methods and compositions for modulating amyloid beta Inactive 20-Aug-2002 G01N33/6896
To view TorreyPines Therapeutics’s complete patent history, request access »

TorreyPines Therapeutics Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Advent International PE/Buyout Minority 000 0000 000000 0
Alta Partners Venture Capital Minority 000 0000 000000 0
Gimv PE/Buyout Minority 000 0000 000000 0
Johnson & Johnson Innovation - JJDC Corporate Venture Capital Minority 000 0000 000000 0
Novartis Venture Fund Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

TorreyPines Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Axonyx 04-Oct-2006 0000000000 Drug Discovery 0000 0000
To view TorreyPines Therapeutics’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

TorreyPines Therapeutics FAQs

  • When was TorreyPines Therapeutics founded?

    TorreyPines Therapeutics was founded in 2000.

  • Where is TorreyPines Therapeutics headquartered?

    TorreyPines Therapeutics is headquartered in San Diego, CA.

  • What industry is TorreyPines Therapeutics in?

    TorreyPines Therapeutics’s primary industry is Biotechnology.

  • Is TorreyPines Therapeutics a private or public company?

    TorreyPines Therapeutics is a Private company.

  • What is TorreyPines Therapeutics’s current revenue?

    The current revenue for TorreyPines Therapeutics is 000000.

  • How much funding has TorreyPines Therapeutics raised over time?

    TorreyPines Therapeutics has raised $60.5M.

  • Who are TorreyPines Therapeutics’s investors?

    Advent International, Alta Partners, Gimv, Johnson & Johnson Innovation - JJDC, and Novartis Venture Fund are 5 of 8 investors who have invested in TorreyPines Therapeutics.

  • When was TorreyPines Therapeutics acquired?

    TorreyPines Therapeutics was acquired on 28-Sep-2009.

  • Who acquired TorreyPines Therapeutics?

    TorreyPines Therapeutics was acquired by Raptor Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »